MM
EW icon

MQS Management’s Edwards Lifesciences EW Stock Holding History

MQS Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,953
Closed -$307K – 486
2025
Q3 		$307K Buy
+3,953
New +$309K 0.18% 256
2024
Q4 		– Sell
-3,708
Closed -$245K – 147
2024
Q3 		$245K Buy
+3,708
New +$269K 0.14% 314
2023
Q4 		– Sell
-3,723
Closed -$258K – 519
2023
Q3 		$258K Buy
+3,723
New +$299K 0.16% 292
2022
Q4 		– Sell
-4,182
Closed -$346K – 433
2022
Q3 		$346K Buy
4,182
+1,245
+42% +$120K 0.22% 176
2022
Q2 		$279K Sell
2,937
-1,329
-31% -$138K 0.19% 242
2022
Q1 		$502K Buy
+4,266
New +$479K 0.41% 68

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

MQS Management's EW Position: Q4 2025 in Review

MQS Management sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 3,953 shares — an estimated $307K sold.

MQS Management first reported a position in EW in Q1 2022 and held it in 6 quarters. The position peaked at $502K in Q1 2022. 1,315 funds tracked by Wall St. Rank hold EW as of Q4 2025.

  • MQS Management reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
  • MQS Management sold 3,953 Edwards Lifesciences shares in Q4 2025, an estimated $307K.
  • MQS Management first reported a position in Edwards Lifesciences in Q1 2022 and held it in 6 quarters.
  • MQS Management's Edwards Lifesciences position peaked at $502K in Q1 2022.
  • 1,315 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on MQS Management's 13F filing for Q4 2025, filed 9 Feb 2026.